5-Amino-1MQ (10 mg Vial) Dosage Protocol

TOC with Icons
Table of Contents

Quickstart Highlights

5-Amino-1MQ dosage protocols center on this selective, cell-permeable NNMT (Nicotinamide N-methyltransferase) inhibitor studied for its potential to support fat metabolism, preserve lean muscle mass, and elevate intracellular NAD+ levels[1][2]. By blocking NNMT, 5-Amino-1MQ may help restore cellular energy balance and activate SIRT1 pathways associated with metabolic efficiency[3]. This educational protocol presents a subcutaneous injection approach to maximize bioavailability from the 10 mg vial format.

  • Reconstitute: Add 2.0 mL bacteriostatic water → 5 mg/mL concentration.
  • Typical daily range: 2.5–5 mg once or twice daily (subcutaneous).
  • Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg (0.05 mg) on a U-100 insulin syringe.
  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 2–4 weeks[4].
  •  

Dosing & Reconstitution Guide

Subcutaneous, once or twice daily

Subcutaneous Protocol (2 mL = 5 mg/mL)

Week

Daily Dose

Units (per injection) (mL)

Days 1–2 (Tolerance)

2.5 mg (2500 mcg)

50 units (0.50 mL)

Days 3+ (Standard)

5 mg (5000 mcg)

100 units (1.00 mL)

Alternative BID

2.5 mg twice daily

50 units (0.50 mL) × 2

Frequency: Inject once or twice daily subcutaneously. Due to the compound’s plasma half-life of approximately 3.8–6.9 hours[5], twice-daily (BID) dosing may provide more sustained NNMT inhibition. A single 10 mg vial provides 2–4 days of material at these doses.

Reconstitution Steps

  1. Remove the vial from freezer storage (−20 °C / −4 °F) and allow to equilibrate at room temperature for 15–20 minutes.
  2. Draw 2.0 mL bacteriostatic water with a sterile syringe.
  3. Inject slowly down the vial wall; avoid foaming.
  4. Gently swirl/roll until dissolved—solution should be clear (do not shake).
  5. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light; use within 2–4 weeks.
Important: This guide is for educational purposes only and is not medical advice.

Supplies Needed

Plan based on protocol duration using the 10 mg vial format at 5 mg/day.

  • 5-Amino-1MQ Vials (10 mg each):
    • 1 week (5 mg/day = 35 mg total) → 4 vials
    • 2 weeks (5 mg/day = 70 mg total) → 7 vials
    • 4 weeks (5 mg/day = 140 mg total) → 14 vials
  • Insulin Syringes (U-100, 1 mL):
    • 1 week (once daily): 7 syringes
    • 2 weeks (once daily): 14 syringes
    • 4 weeks (once daily): 28 syringes
  • Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution.
    • 1 week (4 vials × 2.0 mL = 8 mL) → 1 × 10 mL bottle
    • 2 weeks (7 vials × 2.0 mL = 14 mL) → 2 × 10 mL bottles
    • 4 weeks (14 vials × 2.0 mL = 28 mL) → 3 × 10 mL bottles
  • Alcohol Swabs: One for the vial stopper + one for the injection site each administration.
    • 1 week (once daily): 14 swabs
    • 2 weeks (once daily): 28 swabs
    • 4 weeks (once daily): 56 swabs → recommend 1 × 100-count box

Protocol Overview

Concise summary of the subcutaneous regimen.

  • Goal: Support metabolic efficiency through NNMT inhibition, potentially enhancing fat oxidation and NAD+ levels[1][2].
  • Schedule: Daily subcutaneous injections; each 10 mg vial provides 2–4 days of material.
  • Dose Range: 2.5–5 mg once or twice daily.
  • Reconstitution: 2.0 mL per 10 mg vial (5 mg/mL) for accurate measurements.
  • Storage: Lyophilized frozen at −20 °C (−4 °F); reconstituted refrigerated at 2–8 °C (35.6–46.4 °F).

Dosing Protocol

Suggested approach for the 10 mg vial format.

  • Start: 2.5 mg once daily to assess tolerance.
  • Target: 5 mg once daily or 2.5 mg twice daily (BID).
  • Frequency: Once or twice per day (subcutaneous).
  • Vial Duration: Single 10 mg vial lasts 2–4 days at standard doses.
  • Timing: Morning administration preferred; BID dosing may be split AM/PM.

Storage Instructions

Proper storage preserves compound stability.

  • Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable up to 24 months[4].
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 2–4 weeks.
  • Allow vials to reach room temperature before reconstitution to prevent condensation and pressure issues.
  • Do not refreeze reconstituted solution.

Important Notes

Practical considerations for consistency and safety.

  • Use new sterile insulin syringes for each administration; dispose in a sharps container[6].
  • Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation[7].
  • Inject slowly; a mild stinging sensation may occur due to the quinolinium structure.
  • Document daily dose and site rotation to maintain consistency.
  • The 10 mg vial format requires multiple vials for extended protocols; plan supplies accordingly.

How This Works

5-Amino-1MQ (5-amino-1-methylquinolinium) is a synthetic small molecule that selectively inhibits Nicotinamide N-methyltransferase (NNMT)[1]. NNMT is a cytosolic enzyme that methylates nicotinamide (vitamin B3) using S-adenosylmethionine (SAM) as a methyl donor. In states of obesity and metabolic dysfunction, NNMT is often overexpressed in adipose tissue, depleting nicotinamide and reducing NAD+ availability[2].

By inhibiting NNMT, 5-Amino-1MQ may spare nicotinamide for NAD+ synthesis via the salvage pathway, thereby activating SIRT1 (Sirtuin 1) pathways associated with mitochondrial biogenesis, fat oxidation, and metabolic flexibility[3]. Preclinical studies indicate that NNMT knockdown or inhibition can protect against diet-induced weight gain and improve metabolic parameters without reducing food intake[8][9].

Potential Benefits & Side Effects

Observations from preclinical and early research literature.

  • May support reductions in fat mass while preserving lean muscle in animal models[8][9].
  • Associated with elevated NAD+ levels and SIRT1 activation in preclinical studies[2][3].
  • Enhanced grip strength observed in aged mice when combined with exercise[10].
  • Generally well tolerated; occasional reports of mild headache, transient jitteriness, or injection-site reactions.
  • Long-term human safety data not established; this compound remains investigational.

Lifestyle Factors

Complementary strategies for best outcomes.

  • Pair with a balanced, protein-forward diet tailored to energy needs.
  • Combine resistance training and aerobic activity—preclinical data suggest synergy with exercise[10].
  • Prioritize sleep and stress management to support metabolic adaptation.
  • Consider complementary NAD+ precursors (NMN/NR) per emerging stack protocols[11].

Injection Technique

General subcutaneous guidance from clinical best-practice resources[6].

  • Clean the vial stopper and skin with alcohol; allow to dry.
  • Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[12][13].
  • Do not aspirate for subcutaneous injections; inject slowly and steadily[12].
  • Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[7].
  • Slow injection may minimize any stinging sensation associated with the compound.

Recommended Source

We recommend Pure Lab Peptides for high‑purity SS‑31 (50 mg vials).

Why Pure Lab Peptides?

  • High‑purity, third‑party‑tested peptides with batch‑specific Certificates of Analysis (COAs).
  • Consistent manufacturing processes aligned with quality standards and documented handling procedures.
  • Reliable fulfillment and cold‑chain logistics to maintain peptide integrity during shipping.
  • Transparent product information and responsive customer support.